Pharma, Biotech had outstanding export performance last year
By Kim, Jin-Gu | translator Kim, Jung-Ju
24.04.11 05:50:53
가나다라
0
Samsung Biologics KRW 2.8 trillion→KRW 3.6 trillion 'UP'…15 pharmaceutical companies’ export performance↑
Chong Kun Dang Pharm, a 2.6-fold growth due to technology exports…13 companies with over KRW 100 billion-worth exports
It is reported that 30 of the listed pharmaceutical and biotechnology companies achieved a year-over-year (YoY) growth of 18% in export performance.
Samsung Biologics’ exports significantly increased from KRW 2.85 trillion in 2022 to KRW 3.58 trillion last year. SK Biopharmaceuticals, ST Pharm, and Hanmi Pharmaceutical also experienced notable rises in export performance. Chon Kun Dang Pharmaceutical’s large-scale technology export last year impacted its export figures, which represented an increase of 2.6-fold over a year.
30 major pharmaceutical companies have experienced an 18% increase in export performance…Samsung Biologics has exceeded KRW 3.5 trillion in export figure
Kim, Jin-Gu(kjg@dailypharm.com)
If you want to see the full article, please JOIN US (click)